Skip Navigation LinksHome > Published Ahead-of-Print > Effects of the Cannabinoid-1 Receptor Antagonist/Inverse Ago...
Journal of Clinical Psychopharmacology:
doi: 10.1097/JCP.0b013e3182793843
Letter to the Editors: PDF Only

Effects of the Cannabinoid-1 Receptor Antagonist/Inverse Agonist Rimonabant on Satiety Signaling in Overweight People with Schizophrenia: A Randomized, Double-Blind Pilot Study.

Warren, Kimberly R. PhD; Buchanan, Robert W. MD; Feldman, Stephanie MSW, LCSW-C; Conley, Robert R. MD; Linthicum, Jared MS; Ball, Mary Patricia RN, C, MS; Liu, Fang MS; McMahon, Robert P. PhD; Gorelick, David A. MD, PhD; Huestis, Marilyn A. PhD; Kelly, Deanna L. PharmD, BCPP

Published Ahead-of-Print

Login